Pancragen 20mg*10vials

▎Pancragen Structure

▎Pancragen Research

What is the research background of Pancragen?

The Promotion of Aging and Disease Research: Scientists are committed to finding substances and methods that can intervene in the aging process and improve the symptoms of related diseases. In the study of the aging mechanism, it has been found that the decline of pancreatic function plays an important role in the occurrence and development of many geriatric diseases, which has prompted researchers to focus on bioactive substances that can regulate pancreatic function.

The Exploration of Peptide Substances: Peptide substances have a variety of important physiological functions in the body and are relatively safe with few side effects. Researchers have screened for molecules with the potential to regulate pancreatic function among numerous peptide substances. Through the study of a large number of natural and synthetic peptides, it has been found that some peptides with specific amino acid sequences may have a regulatory effect on the function of pancreatic cells.

The Discovery of Pancragen: After a series of experiments and screenings, researchers discovered the tetrapeptide Pancragen, with an amino acid sequence of Lys-Glu-Asp-Trp. Further research has shown that Pancragen has exhibited positive effects on pancreatic cells in cell experiments and animal models, such as promoting pancreatic cell differentiation and regulating the secretion of insulin and glucagon, laying the foundation for its subsequent clinical research and application.

What is the mechanism of action of Pancragen?

1. Effects on Pancreatic Cell Differentiation

Stimulating the Expression of Differentiation Factors: As pancreatic cells age, the expression of their differentiation markers decreases. Pancragen can stimulate the expression of differentiation factors in pancreatic cells, including stimulating the expression of differentiation factors in acinar cells (Pdx1, Ptfla) and islet cells. This effect is observed in both "young" and "old" cultures^[1]. This stimulating effect helps maintain the normal function of pancreatic cells. Especially during the aging process, it can promote cell differentiation, thereby enhancing the overall function of the pancreas.

Anti-diabetic and Anti-inflammatory Mechanisms: The differentiation of pancreatic acinar cells and islet cells induced by Pancragen may be one of the mechanisms of its anti-diabetic and anti-inflammatory effects. By promoting the differentiation of pancreatic cells, Pancragen can regulate the function of pancreatic cells, enabling them to better regulate blood glucose levels, and may also reduce the inflammatory response ^[1]. Transcription factors play an important regulatory role in the differentiation of pancreatic cells, and Pancragen targets these transcription factors pharmacologically, making it an effective tool for the treatment of diabetes and pancreatitis^[1].

2. Effects on the Endocrine Function of the Pancreas in Elderly Monkeys

Improving Glucose Metabolism: In elderly monkeys, after administering a standard dose of glucose, compared with young monkeys, the glucose "disappearance" rate in elderly monkeys is lower, and the peak levels of insulin and C-peptide (5 minutes and 15 minutes after glucose injection) are higher. The administration of Pancragen (the tetrapeptide Lys-Glu-Asp-Trp) (50μg per animal per day, intramuscular injection, for 10 days) can significantly increase the glucose "disappearance" rate in elderly monkeys and normalize the kinetics of the plasma insulin and C-peptide response to glucose ^[2].

Sustained Restoration Effect: The effect of Pancragen on restoring pancreatic function persists partially after the drug is withdrawn. Three weeks after stopping the drug, the effect of Pancragen on restoring the pancreatic function of elderly monkeys is still retained to a certain extent, indicating that Pancragen may have a long-term therapeutic effect^[2].

3. Correction of Metabolic Disorders in the Elderly

Reducing Blood Glucose and Insulin Levels: In elderly patients with type 2 diabetes, Pancragen can significantly reduce the glucose levels during fasting and in the standard glucose tolerance test, and also reduce the insulin concentration and insulin resistance index in the plasma. For patients who did not receive Pancragen treatment, no changes in the carbohydrate metabolism index were observed. This indicates that Pancragen has a corrective effect on the metabolic disorders of the elderly, especially for elderly patients with type 2 diabetes^[3].

Improving Insulin Resistance: The disorder of the pineal melatonin production function in the elderly contributes to the development of insulin resistance. The administration of Pancragen is a promising method for correcting insulin resistance in the elderly. In elderly patients, the Pancragen peptide has an additional hypoglycemic effect on type 2 diabetes, especially in patients with high initial insulin resistance and hyperinsulinemia. Under the influence of the peptide preparation, the Homa insulin resistance index decreases^[4].

What are the applications of Pancragen?

1. Anti-aging Effect

 As people age, the function of pancreatic cells gradually declines. Pancragen can stimulate the expression of various differentiation factors in pancreatic cells, enhance cell activity, and improve the function of pancreatic cells, thus delaying the aging process of the pancreas to a certain extent. Aging leads to the decline of pancreatic cell function and increases the risk of metabolic diseases such as diabetes. Pancragen may delay the aging process of pancreatic cells by stimulating the expression of differentiation factors in pancreatic cells. For example, in some animal experiments, Pancragen can improve the function of pancreatic cells in elderly animals and delay the aging process of the pancreas ^[4].

2. Supporting Pancreatic Cell Differentiation

Pancragen can interact with the DNA sequences in pancreatic cells, affect gene expression, and thus promote the differentiation of pancreatic cells, maintaining the normal structure and function of the pancreas. This mechanism of action indicates that Pancragen may initiate the signaling pathway of pancreatic cell differentiation by regulating the expression of specific genes. For example, studies have found that Pancragen can stimulate the expression of some key differentiation factors in pancreatic cells^[1]. Transcription factors play a crucial role in the differentiation process of pancreatic cells. They can regulate the development and function of pancreatic cells and maintain the normal physiological function of the pancreas.

3. Regulating Insulin and Glucagon Secretion

In research, Pancragen has shown a supporting effect on the endocrine function of the pancreas, helping to regulate the secretion of insulin and glucagon and maintain blood glucose balance. Insulin and glucagon are important hormones for regulating blood glucose levels, and the balance of their secretion is crucial for maintaining stable blood glucose levels. Pancragen may regulate the secretion of insulin and glucagon by affecting the function of pancreatic cells. For example, in animal experiments, Pancragen can lower blood glucose levels and regulate the levels of insulin and C-peptide^[5]. This indicates that Pancragen may improve glucose metabolism and maintain blood glucose balance by regulating the endocrine function of the pancreas.

4. Promoting Blood Glucose Balance

Improving Insulin Resistance: Pancragen has a potential role in regulating blood glucose levels. It can lower fasting blood glucose levels, reduce insulin concentration and the insulin resistance index, and thus have a positive impact on improving insulin resistance. Insulin resistance is one of the important pathogenesis of type 2 diabetes, and improving insulin resistance can effectively prevent and treat diabetes. Pancragen may regulate the uptake and utilization of glucose by cells, lower blood glucose levels, and reduce insulin secretion, thereby improving insulin resistance. For example, in some animal model studies, Pancragen can lower blood glucose levels and improve insulin resistance^{[2, 4]}.

Regulating Glucose Metabolism: It may regulate the uptake and utilization of glucose by cells by affecting key enzymes in glucose metabolism, helping to maintain stable blood glucose levels, which is of great significance for preventing and improving metabolic disorders such as metabolic syndrome. Glucose metabolism is an important process for maintaining normal physiological functions of the human body. Regulating glucose metabolism can effectively prevent and treat metabolic diseases such as diabetes. Pancragen may regulate the uptake and utilization of glucose by cells by affecting key enzymes in glucose metabolism, such as glucose transporters and hexokinase, to maintain stable blood glucose levels. For example, in some animal experiments, Pancragen can regulate glucose metabolism and improve blood glucose levels^{[2, 4]}.

5. Supporting Endocrine Function

Maintaining Hormone Balance: The regulatory effect of Pancragen on the endocrine function of the pancreas helps maintain the balance of hormone levels in the body, especially the balance between insulin and glucagon, which is crucial for overall metabolic health. Insulin and glucagon are important hormones for regulating blood glucose levels, and the balance of their secretion is crucial for maintaining stable blood glucose levels. Pancragen may maintain the balance between insulin and glucagon by regulating the function of pancreatic cells. For example, in some animal experiments, Pancragen can regulate the secretion of insulin and glucagon and maintain stable blood glucose levels ^{[2, 4]}.

6. Diabetes Management

Regulating Blood Glucose and Insulin Levels: In some studies, Pancragen has shown an effect of lowering blood glucose levels comparable to that of commonly used hypoglycemic drugs. At the same time, it can more effectively regulate the levels of insulin and C-peptide, and is expected to become a new treatment for diabetes. Diabetes is a serious metabolic disease, and controlling blood glucose levels is the key to diabetes treatment. Pancragen may lower blood glucose levels and regulate the levels of insulin and C-peptide by regulating the endocrine function of the pancreas. For example, in some animal experiments, Pancragen can lower blood glucose levels and regulate the levels of insulin and C-peptide, with an effect comparable to that of commonly used hypoglycemic drugs^{[2, 4, 5]}.

Protecting Pancreatic β-cell Function: By improving the function and activity of pancreatic cells, Pancragen may help protect pancreatic β-cells and slow down the progression of diabetes, which is of great significance for the prevention and treatment of diabetes. Pancreatic β-cells are the main cells that secrete insulin, and protecting the function of pancreatic β-cells is crucial for the prevention and treatment of diabetes. Pancragen may protect pancreatic β-cells by improving the function and activity of pancreatic cells.

7. Treatment of Chronic Pancreatitis

Reducing Inflammatory Response: Pancragen has a certain anti-inflammatory effect, which can reduce the inflammatory response of the pancreas and relieve the symptoms of chronic pancreatitis. Chronic pancreatitis is a common pancreatic disease, and the inflammatory response is one of the important pathological features of chronic pancreatitis. Pancragen may reduce the inflammatory response of the pancreas by regulating the expression of inflammatory factors. For example, in some animal experiments, Pancragen can reduce the inflammatory response of the pancreas and relieve the symptoms of chronic pancreatitis.

Promoting Pancreatic Tissue Repair: It may promote the repair and regeneration of pancreatic tissue by regulating cell proliferation and differentiation, helping to improve the functional state of the pancreas. The repair and regeneration of pancreatic tissue are crucial for the treatment of chronic pancreatitis. Pancragen can promote the repair and regeneration of pancreatic tissue by regulating cell proliferation and differentiation. For example, in some animal experiments, Pancragen can promote the repair and regeneration of pancreatic tissue and improve the functional state of the pancreas.

In conclusion, Pancragen plays an important role in exerting anti-aging effects, regulating pancreatic function, promoting blood glucose balance, supporting endocrine function, as well as in diabetes management and the treatment of chronic pancreatitis.

About The Author

The above-mentioned materials are all researched, edited and compiled by Cocer Peptides.

Scientific Journal Author

Khavinson V K is a distinguished researcher with extensive affiliations across multiple prestigious institutions. These include the Russian Academy of Sciences, St Petersburg Institute of Bioregulation and Gerontology, North-Western State Medical University named after I.I. Mechnikov, Pavlov Institute of Physiology, Russian Academy of Medical Sciences, and Peter the Great St. Petersburg Polytechn c University, among others.

His research interests span a wide array of fields such as Research & Experimental Medicine, Geriatrics & Gerontology, Biochemistry & Molecular Biology, Endocrinology & Metabolism, and Neurosciences & Neurology. Throughout his career, he has made significant contributions to these areas, advancing the understanding of various biological processes and medical conditions.

▎Relevant Citations

[1]    Khavinson V K, Durnova A O, Polyakova V O, et al. Effects of pancragen on the differentiation of pancreatic cells during their  ageing[J]. Bulletin of Experimental Biology and Medicine, 2013,154(4):501-504.DOI:10.1007/s10517-013-1987-6.

[2]    Goncharova N D, Ivanova L G, Oganian T É, et al. Impact of tetrapeptide pancragen on endocrine function of the pancreas in old  monkeys[J]. Advances in Gerontology, 2014,27(4):662-667. https://pubmed.ncbi.nlm.nih.gov/25946840/.

[3]    Korkushko O V, Khavinson V K, Shatilo V B, et al. Prospects of using pancragen for correction of metabolic disorders in elderly  people[J]. Bulletin of Experimental Biology and Medicine, 2011,151(4):454-456.DOI:10.1007/s10517-011-1354-4.

[4]    Korkushko O, Shatilo V, Havinson W, et al. Efficacy of pancragen peptide in elderly patients with type 2 diabetes mellitus[J]. Problems of Endocrine Pathology, 2010,33:5-10.DOI:10.21856/j-PEP.2010.3.01.

[5]    Goncharova N D, Ivanova L G, Oganyan T E, et al. Correction of impaired glucose tolerance using tetrapeptide (Pancragen) in old  female rhesus monkeys[J]. Advances in Gerontology, 2015,28(3):579-585. https://pubmed.ncbi.nlm.nih.gov/28509500/.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.  

The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.